Glihypo-Plus 10 Tablet
Images are for reference. Actual packaging may vary.
Rosuvastatin (10mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Alternative MRP ₹130.0018% off MRP
Compare pack sizes and check with your doctor or pharmacist before switching medicines.
Active composition
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Medical applications
Glihypo-Plus 10 Tablet contains Rosuvastatin 10mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C).
Rosuvastatin exerts its therapeutic effect by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing hepatic cholesterol production and enhancing clearance of LDL particles from the bloodstream. Glihypo-Plus 10 Tablet is prescribed as an adjunct to diet, exercise, and lifestyle modifications for patients with primary hyperlipidemia or familial hypercholesterolemia and for the prevention of cardiovascular disease in high-risk individuals.
It is also used in patients with mixed dyslipidemia to improve lipid profiles. The recommended dosage should be individualized based on patient response and risk factors, with regular monitoring of lipid levels and liver function tests advised during therapy. Common adverse effects include myalgia, headache, and gastrointestinal disturbances, while rare but serious effects such as myopathy and hepatotoxicity require prompt medical attention.
Caution is advised in patients with hepatic impairment or those taking concomitant medications that may interact with Rosuvastatin.
Phenylpyrimidine derivatives
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Glihypo-Plus 10 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Glihypo-Plus 10 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Glihypo-Plus 10 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glihypo-Plus 10 Tablet may be needed. Please consult your doctor. Use of Glihypo-Plus 10 Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Glihypo-Plus 10 Tablet does not usually affect your ability to drive.
Consult Doctor
Glihypo-Plus 10 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glihypo-Plus 10 Tablet may be needed. Please consult your doctor. Use of Glihypo-Plus 10 Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for Glihypo-Plus 10 Tablet







